.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Argus Health
Mallinckrodt
US Army
Johnson and Johnson
Medtronic
Daiichi Sankyo
Fuji
Federal Trade Commission

Generated: June 26, 2017

DrugPatentWatch Database Preview

ELLENCE Drug Profile

« Back to Dashboard

What is the patent landscape for Ellence, and what generic Ellence alternatives are available?

Ellence is a drug marketed by Pfizer Inc and is included in one NDA.

The generic ingredient in ELLENCE is epirubicin hydrochloride. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epirubicin hydrochloride profile page.

Summary for Tradename: ELLENCE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list51
Clinical Trials: see list13
Patent Applications: see list4,279
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ELLENCE at DailyMed

Pharmacology for Tradename: ELLENCE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc
ELLENCE
epirubicin hydrochloride
INJECTABLE;INJECTION050778-001Sep 15, 1999APRXYesYes► Subscribe► Subscribe
Pfizer Inc
ELLENCE
epirubicin hydrochloride
INJECTABLE;INJECTION050778-002Sep 15, 1999APRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
McKesson
Cerilliant
Covington
Johnson and Johnson
Accenture
Federal Trade Commission
Colorcon
Daiichi Sankyo
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot